Milestone Pharmaceuticals (MIST) Stock Analysis
NASDAQHealthcareBiotechnology
What Milestone Pharmaceuticals does
Milestone Pharmaceuticals Inc. is a biopharmaceutical company based in Montréal, Canada, specializing in the creation and commercialization of cardiovascular therapeutics. Their flagship product, etripamil, an innovative channel blocker, is currently in advanced clinical development. It is undergoing Phase III trials for the treatment of paroxysmal supraventricular tachycardia (PSVT) in the United States and Canada, while also progressing through Phase II trials for atrial fibrillation and rapid ventricular rate. Furthermore, Milestone Pharmaceuticals has forged a licensing and collaboration alliance with Ji Xing Pharmaceuticals to advance and distribute etripamil for both preventative and therapeutic applications in humans. The company was founded in 2003.
Key metrics
ETFs linked to MIST
Broad-market and Healthcare sector ETFs an investor holding Milestone Pharmaceuticals is often also exposed to. Open an ETF page to see its actual top holdings.
PortView Portfolio Insights
PortView analyzes how MIST fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.
Analyze MIST in PortView →Similar companies
Frequently asked questions
- What is the ticker symbol for Milestone Pharmaceuticals?
- Milestone Pharmaceuticals trades under the ticker MIST on NASDAQ.
- Which exchange is MIST listed on?
- MIST is listed on NASDAQ.
- What sector does Milestone Pharmaceuticals operate in?
- Milestone Pharmaceuticals is classified in the Healthcare sector (Biotechnology industry).
- How can PortView help analyze MIST in a portfolio?
- PortView shows MIST's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.
The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.